Photo detail


Stories this photo appears in:

Capricor Inks Commercialization Deal with Japanese Firm

Beverly Hills-based biotechnology company Capricor Therapeutics Inc. announced on Jan. 25 a major commercialization and distribution deal with a Japanese pharmaceutical company for its drug to treat the rare degenerative genetic disease Duchene muscular dystrophy.

Tease photo